Shopping Cart
- Remove All
 
Your shopping cart is currently empty
NRA-0160 is a selective antagonist of dopamine D4 receptor(Ki of 0.48 nM)

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 
| Description | NRA-0160 is a selective antagonist of dopamine D4 receptor(Ki of 0.48 nM)  | 
| Targets&IC50 |  α1-adrenoceptor (rat):237 nM (ki), D4 receptor:0.48 nM (ki), 5-HT2A receptor:180 nM (Ki, in rat), D3 receptor:39 nM (ki)  | 
| In vivo | NRA0160 dose-dependently and significantly reverses the effects of MAP on both A9 and Al0 dopamine neurons.?NRA0160 is slightly more potent in reversiig the effects of MAP on A10 (ED50 = 1.0 mg/kg) than on A9 dopamine neurons (ED50 = 1.3 mg/kg).?NRA0160 reverses the effect of AP0 on both A9 and A10 dopamine neurons.?ED50 values for the effects of NRA0160 on APO-induced inhibition of A9 and A10 dopamine neurons are 1.3 mg/kg and 0.5 mg/kg, respectively[2].  | 
| Molecular Weight | 439.52 | 
| Formula | C24H23F2N3OS | 
| Cas No. | 204718-47-8 | 
| Relative Density. | 1.297 g/cm3 (Predicted) | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.